Publications

Found 167 results
Filters: Fenretinide-improves-intestinal-barrier-function-and-mitigates-alcohol-liver-disease-0 is   [Clear All Filters]
2026
Chi Y, DiKun KM, Tang X-H, Warren CD, Chikara S, Del Aguila EMere, Wagner JA, Geri JB, Gudas LJ.  2026.  Retinoic acid receptor β deletion in podocytes causes kidney and liver dysfunction, modeling nephrotic syndrome.. J Mol Endocrinol. 76(1)
2025
Chi Y, Del Aguila EMere, Zhang T, Warren CD, Hoxie HR, Chen Q, Gross SS, Geri JB, Nanus DM, Gudas LJ.  2025.  ATF4 in proximal tubules modulates kidney function and modifies the metabolome.. J Mol Med (Berl).
Chi Y, Chikara S, Del Aguila EMere, Zhang T, Geri JB, Nanus DM, Gudas LJ.  2025.  Deletion of the transcription factor ATF4 in a model of clear cell renal cell carcinoma.. Neoplasia. 66:101188.
Tang X-H, Pesola G, Chen Q, Miller D, Nagy LE, McMullen MR, Schwartz RE, Tsoy S, Lim C, Chikara S et al..  2025.  Ethanol causes rapid decreases in the hepatic retinoid levels shaping the early steps of alcohol-associated liver disease.. Alcohol Clin Exp Res (Hoboken).
Baquero J, Tang X-H, Galke D, Scognamiglio T, Zhang T, Miller D, Chen Q, Gross S, Gudas LJ.  2025.  Exogenous BMI1 expression aggravates oral squamous cell carcinomas in tongue epithelia.. Neoplasia. 62:101146.
Harris AE, Lothion-Roy J, Thompson RL, Haque M, Woodcock CL, Alsaleem MA, Dean A, Kariri Y, Toss MS, Gudas LJ et al..  2025.  Functional and clinical significance of the RNA m6A methyltransferase complex in breast cancer.. NPJ Breast Cancer. 11(1):147.
Baquero J, Tang X-H, Galke D, Scognamiglio T, Zhang T, Gudas LJ.  2025.  Key early changes in oral squamous cell carcinogenesis are accelerated by ectopic BMI1 expression.. Cancer Res Commun.
Hoxie HR, Tang X-H, Gudas LJ.  2025.  Multiple modes of transcriptional regulation by the nuclear hormone receptor RARγ in human squamous cell carcinoma.. J Biol Chem. 302(1):110965.
Del Aguila EMere, Tang X-H, Gudas LJ.  2025.  Retinoic acid receptor-β deletion in a model of early pancreatic ductal adenocarcinoma (PDAC) tumorigenesis.. Am J Cancer Res. 15(1):127-140.
2024
Patke R, Harris AE, Woodcock CL, Thompson R, Santos R, Kumari A, Allegrucci C, Archer N, Gudas LJ, Robinson BD et al..  2024.  Epitranscriptomic mechanisms of androgen signalling and prostate cancer.. Neoplasia. 56:101032.
DiKun KM, Tang X-H, Fu L, Choi ME, Lu C, Gudas LJ.  2024.  Retinoic acid receptor α activity in proximal tubules prevents kidney injury and fibrosis.. Proc Natl Acad Sci U S A. 121(7):e2311803121.
Baquero J, Tang X-H, Ferrotta A, Zhang T, DiKun KM, Gudas LJ.  2024.  The transcription factor bmi1 increases hypoxic signaling in oral cavity epithelia.. Biochim Biophys Acta Mol Basis Dis. :167161.
2023
Metzler VM, de Brot S, Haigh DB, Woodcock CL, Lothion-Roy J, Harris AE, Nilsson EM, Ntekim A, Persson JL, Robinson BD et al..  2023.  The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer.. Front Cell Dev Biol. 11:1116424.
Kubala JM, Laursen KB, Schreiner R, Williams RM, van der Mijn JC, Crowley MJ, Mongan NP, Nanus DM, Heller DA, Gudas LJ.  2023.  NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma.. Cancer Biol Ther. 24(1):2170669.
van der Mijn JC, Laursen KB, Fu L, Khani F, Dow LE, Nowak DG, Chen Q, Gross SS, Nanus DM, Gudas LJ.  2023.  Novel genetically engineered mouse models for clear cell renal cell carcinoma.. Sci Rep. 13(1):8246.
Melis M, Trasino SE, Tang X-H, Rappa A, Zhang T, Qin L, Gudas LJ.  2023.  Retinoic Acid Receptor β Loss in Hepatocytes Increases Steatosis and Elevates the Integrated Stress Response in Alcohol-Associated Liver Disease.. Int J Mol Sci. 24(15)
Zhang T, Kutler D, Scognamiglio T, Gudas LJ, Tang X-H.  2023.  Transcriptomic analysis predicts the risk of progression of premalignant lesions in human tongue.. Discov Oncol. 14(1):24.
DiKun KM, Gudas LJ.  2023.  Vitamin A and retinoid signaling in the kidneys.. Pharmacol Ther. 248:108481.
2022
Benjamin DN, O'Donovan TR, Laursen KB, Orfali N, Cahill MR, Mongan NP, Gudas LJ, McKenna SL.  2022.  All-Trans-Retinoic Acid Combined With Valproic Acid Can Promote Differentiation in Myeloid Leukemia Cells by an Autophagy Dependent Mechanism.. Front Oncol. 12:848517.
Lothion-Roy J, Haigh DB, Harris AE, Metzler VM, Alsaleem M, Toss MS, Kariri Y, Ntekim A, Robinson BD, Khani F et al..  2022.  Clinical and molecular significance of the RNA m6A methyltransferase complex in prostate cancer.. Front Genet. 13:1096071.
Harris AE, Metzler VM, Lothion-Roy J, Varun D, Woodcock CL, Haigh DB, Endeley C, Haque M, Toss MS, Alsaleem M et al..  2022.  Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer.. Front Endocrinol (Lausanne). 13:1006101.
Melis M, Tang X-H, Mai K, Gudas LJ, Trasino SE.  2022.  Fenretinide Reduces Intestinal Mucin-2-Positive Goblet Cells in Chronic Alcohol Abuse.. Pharmacology. :1-11.
van der Mijn JC, Eng KW, Chandra P, Fernandez E, Ramazanoglu S, Sigaras A, Oromendia C, Gudas LJ, Tagawa ST, Nanus DM et al..  2022.  The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy.. Mol Oncol.
Haigh DB, Woodcock CL, Lothion-Roy J, Harris AE, Metzler VM, Persson JL, Robinson BD, Khani F, Alsaleem M, Ntekim A et al..  2022.  The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate Cancer.. Cancers (Basel). 14(20)
Del Aguila EMere, Tang X-H, Gudas LJ.  2022.  Pancreatic Ductal Adenocarcinoma: New Insights into the Actions of Vitamin A.. Oncol Res Treat.